U.S. markets closed

22nd Century Group, Inc. (XXII)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
4.7900+0.1700 (+3.68%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close4.6200
Open4.6600
Bid4.8000 x 1200
Ask4.9000 x 4000
Day's Range4.5800 - 4.8400
52 Week Range0.5500 - 6.0700
Volume2,112,108
Avg. Volume4,239,288
Market Cap778.696M
Beta (5Y Monthly)1.85
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Four Cannabis Stocks for the Summer of 2021
    GlobeNewswire

    Four Cannabis Stocks for the Summer of 2021

    Cannabis stocks have resumed their upward trend. Here are four stocks to consider.ATLANTA, June 10, 2021 (GLOBE NEWSWIRE) -- Cannabis stocks have staged a rousing return in recent weeks after a quiet first half of 2021. Sales are on the rise this year as revenue and profits for many cannabis companies have increased significantly. During the global COVID-19 pandemic medical marijuana was deemed "essential,” which definitely had an impact on increased sales. U.S. legal cannabis sales grew 46% yea

  • 22nd Century Announces Closing of $40 Million Common Stock Registered Direct Offering
    GlobeNewswire

    22nd Century Announces Closing of $40 Million Common Stock Registered Direct Offering

    Financing Provides Support to the Company’s Strategic Objectives Across All Its Plant Franchises.BUFFALO, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that it closed the previously announced sale of 10 million shares of its common stock at a purchase price of $4.00 per share in a registered direct offering

  • Reduced Nicotine Tobacco and Cannabinoid Innovator 22nd Century Group to Be Added to Russell 2000®, Russell 3000®, and Russell Global Indexes
    GlobeNewswire

    Reduced Nicotine Tobacco and Cannabinoid Innovator 22nd Century Group to Be Added to Russell 2000®, Russell 3000®, and Russell Global Indexes

    BUFFALO, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, is pleased to announce that it will be added to the Russell 2000®, Russell 3000®, and Russell Global Indexes at the conclusion of the Russell US Indexes annual reconstitution, effective at the opening of the U.S. equity markets on June 28, 2021. “It is an honor to join